Quarterly report pursuant to Section 13 or 15(d)

Related Party Agreements (Details)

v3.21.2
Related Party Agreements (Details)
 1 Months Ended 3 Months Ended 6 Months Ended
Mar. 17, 2015
USD ($)
item
Dec. 31, 2016
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Management Services Agreement [Member]            
Related Party Transaction [Line Items]            
Number of period 5 years          
Annual Consulting Fee $ 500,000          
Increase In Annual Consulting Fee 1,000,000.0          
Excess In Net Assets Value 100,000,000          
Costs and Expenses, Related Party     $ 125,000 $ 125,000 $ 250,000 $ 250,000
Fortress Biotech, Inc [Member] | Founders Agreement [Member]            
Related Party Transaction [Line Items]            
Long-term Debt, Gross $ 2,800,000          
Issuance of Common Stock, Percentage of Outstanding Diluted Equity 2.50%          
Number of Business Days 5 days          
Voting equity, Percentage of Equity or Debt Financing 2.50%          
Cash Fee, Percentage of Annual Net Sales 4.50%          
Cash Fees, Maximum Number of Days 90 days          
Control Fees, Number of Times | item 5          
Control Fees, Monthly Net Sales 12 months          
Cash Fee, Percentage of Monthly Net Sales 4.50%          
Agreement Term 15 years          
Caribe Bioadvisors LLC [Member]            
Related Party Transaction [Line Items]            
Costs and Expenses, Related Party     28,000 28,000 55,000 56,000
Annual Advisory Service Fee   $ 60,000        
Caribe Bioadvisors LLC [Member] | Equity Incentive Grants [Member]            
Related Party Transaction [Line Items]            
Costs and Expenses, Related Party     $ 13,000 $ 13,000 $ 25,000 $ 26,000